PMID- 35245984 OWN - NLM STAT- MEDLINE DCOM- 20220405 LR - 20220715 IS - 1092-874X (Electronic) IS - 1091-5818 (Linking) VI - 41 IP - 2 DP - 2022 Mar-Apr TI - Polysorbate 80-Induced Anaphylactoid Reaction and the Effects on Cardiovascular Function: Dose Threshold and Species Comparison. PG - 99-107 LID - 10.1177/10915818211072780 [doi] AB - Polysorbate 80 (PS80) is commonly used in pre-clinical formulations. The dose threshold for cardiovascular (CV) changes and hypersensitivity reaction in the dog was assessed and compared to other species. PS80 was administered by intravenous (IV) bolus (.5, 1 mg/kg), IV infusion (.3, .5, 1, 3 mg/kg), subcutaneous (SC) injection (5, 10, 15 mg/kg) and oral gavage (10 mg/kg) to dogs with CV monitoring. Monkeys and minipigs received PS80 by IV infusion at 3 mg/kg. Plasma histamine concentration was measured following PS80 IV infusion and with diphenhydramine pre-treatment in dogs only. In dogs, PS80 was not associated with CV changes at doses up to 15 mg/kg SC and 10 mg/kg oral, but decreased blood pressure and increased heart rate with IV bolus at >/= .5 mg/kg and IV infusion at >/= 1.0 mg/kg and decreased body temperature with IV infusion at 3 mg/kg was observed. Transient edema and erythema were noted with all administration routes, in all three species including doses that were devoid of CV effects. In monkeys and minipigs, PS80 did not induce CV, cutaneous or histamine concentration changes. These results suggest that mild, transient skin changes occur following PS80 administration at doses that are not associated with CV effects in the dogs. In dogs, the cardiovascular effect threshold was <.5 mg/kg for IV bolus, .3 mg/kg for IV infusion, 15 mg/kg for SC injection, and 10 mg/kg for oral administration. Monkey and minipig were refractory to PS80-induced histamine release at 3 mg/kg by IV infusion over 15 minutes. FAU - Pouliot, Mylene AU - Pouliot M AD - Charles River Laboratories Montreal ULC, Laval, QC, Canada. FAU - Bussiere, Jeanine AU - Bussiere J AD - 7129Amgen Inc, Thousand Oaks, CA, USA. FAU - Coppi, Aldo AU - Coppi A AD - 7129Amgen Inc, Thousand Oaks, CA, USA. FAU - Holbrook, Kristen AU - Holbrook K AUID- ORCID: 0000-0001-6923-3580 AD - 7129Amgen Inc, Thousand Oaks, CA, USA. FAU - Shelton, Amy AU - Shelton A AD - 7412Genentech Inc, South San Francisco, CA, USA. FAU - Sparapani, Samantha AU - Sparapani S AD - Charles River Laboratories Montreal ULC, Laval, QC, Canada. FAU - Maher, Jonathan AU - Maher J AD - 7406Theravance Biopharma, Inc. South San Francisco, CA, USA. FAU - Zabka, Tanja S AU - Zabka TS AD - 7412Genentech Inc, South San Francisco, CA, USA. FAU - Boulay, Emmanuel AU - Boulay E AD - Charles River Laboratories Montreal ULC, Laval, QC, Canada. AD - Faculty of Veterinary Medicine, University of Montreal, St-Hyacinthe, QC, Canada. FAU - Authier, Simon AU - Authier S AUID- ORCID: 0000-0001-8134-4558 AD - Charles River Laboratories Montreal ULC, Laval, QC, Canada. AD - Faculty of Veterinary Medicine, University of Montreal, St-Hyacinthe, QC, Canada. LA - eng PT - Journal Article DEP - 20220304 PL - United States TA - Int J Toxicol JT - International journal of toxicology JID - 9708436 RN - 0 (Polysorbates) RN - 820484N8I3 (Histamine) SB - IM MH - *Anaphylaxis/chemically induced MH - Animals MH - Dogs MH - Histamine MH - Injections, Intravenous MH - *Polysorbates/toxicity MH - Swine MH - Swine, Miniature OTO - NOTNLM OT - beagle dog OT - blood pressure OT - body temperature OT - cynomolgus monkey OT - gottingen minipig OT - heart rate OT - histamine OT - polysorbate 80 OT - tween 80 EDAT- 2022/03/06 06:00 MHDA- 2022/04/06 06:00 CRDT- 2022/03/05 05:24 PHST- 2022/03/06 06:00 [pubmed] PHST- 2022/04/06 06:00 [medline] PHST- 2022/03/05 05:24 [entrez] AID - 10.1177/10915818211072780 [doi] PST - ppublish SO - Int J Toxicol. 2022 Mar-Apr;41(2):99-107. doi: 10.1177/10915818211072780. Epub 2022 Mar 4.